HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia

Human Immunology

Volumn 70, Issue 6, 2009, Pages 461-463

  Ilonen, Jorma ^a,b   Kocova, Mirjana ^c   Lipponen, Kati ^a   Sukarova Angelovska, Elena ^c   Jovanovska, Aleksandra ^c   Knip, Mikael ^d,e  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Macedonia)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

HLA genes; Incidence; Macedonia; Type 1 diabetes

Indexed keywords

HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR11 ANTIGEN; HLA DR3 ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; MACEDONIA (REPUBLIC); MALE;

EID: 67349122311     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.03.014     Document Type: Article

References (19)

1. Kocova M., Trucco M., Konstantinova M., and Dorman J.S. A cold spot of IDDM incidence in Europe. Macedonia. Diabetes Care 16 (1993) 1236-1240
2. Kocova M., Blagoevska M., Bogoevski M., Konstantinova M., Dorman J., and Trucco M. HLA class II molecular typing in an European Slavic population with a low incidence of insulin-dependent diabetes mellitus. Tissue Antigens 45 (1995) 216-219
3. Arnaiz-Villena A., Dimitroski K., Pacho A., Moscoso J., Gomez-Casado E., Silvera-Redondo C., et al. HLA genes in Macedonians and the sub-Saharan origin of the Greeks. Tissue Antigens 57 (2001) 118-127
4. Hermann R., Turpeinen H., Laine A.P., Veijola R., Knip M., Simell O., et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families. Tissue Antigens 62 (2003) 162-169
5. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the type 1 diabetes genetics consortium families. Diabetes 57 (2008) 1084-1092
6. Lambert A.P., Gillespie K.M., Thomson G., Cordell H.J., Todd J.A., Gale E.A., and Bingley P.J. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: A population-based study in the United Kingdom. J Clin Endocrinol Metab 89 (2004) 4037-4043
7. Thomson G., Valdes A.M., Noble J.A., Kockum I., Grote M.N., Najman J., et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis. Tissue Antigens 70 (2007) 110-127
8. Ronningen K.S., Keiding N., and Green A. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44 Suppl 3 (2001) B51-B59
9. Kockum I., Sanjeevi C.B., Eastman S., Landin-Olsson M., Dahlquist G., and Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 26 (1999) 361-372
10. EURODIAB ACE StudyGroup. Variation and trends in incidence of chidhood diabetes in Europe. Lancet 355 (2000) 873-876
11. Mamoulakis D., Galanakis E., Bicouvarakis S., Paraskakis E., and Sbyrakis S. Epidemiology of childhood type I diabetes in Crete, 1990-2001. Acta Paediatr 92 (2003) 737-739
12. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18 (2006) 207-213
13. Laine A.P., Holmberg H., Nilsson A., Ortqvist E., Kiviniemi M., Vaarala O., et al. Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populations. Dis Markers 23 (2007) 139-145
14. Lampis R., Morelli L., Congia M., Macis M.D., Mulargia A., Loddo M., et al. The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 9 (2000) 2959-2965
15. Petrone A., Bugawan T.L., Mesturino C.A., Nistico L., Galgani A., Giorgi G., et al. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 58 (2001) 385
16. Petrone A., Battelino T., Krzisnik C., Bugawan T., Erlich H., Di Mario U., et al. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60 (2002) 244-253
17. Arnaiz-Villena A., Iliakis P., Gonzalez-Hevilla M., Longas J., Gomez-Casado E., Sfyridaki K., et al. The origin of Cretan populations as determined by characterization of HLA alleles. Tissue Antigens 53 (1999) 213-226
18. Klitz W., Maiers M., Spellman S., Baxter-Lowe L.A., Schmeckpeper B., Williams T.M., and Fernandez-Vina M. New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62 (2003) 296-307
19. Libman I.M., LaPorte R.E., Becker D., Dorman J.S., Drash A.L., and Kuller L. Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania?. Diabetes Care 21 (1998) 1278-1281